渝三峡Ａ：10月24日召开董事会会议

Group 1 - The core point of the article is that Yuzhong Sanxia A announced a board meeting to discuss the disposal of part of its shares in Beilu Pharmaceutical, indicating potential strategic moves in its investment portfolio [1] - For the first half of 2025, Yuzhong Sanxia A's revenue composition is entirely from the manufacturing sector, with a 100.0% share [1] - As of the report date, Yuzhong Sanxia A has a market capitalization of 3.6 billion yuan [1] Group 2 - A notable transaction was reported where a well-known brand spent 170 million yuan to acquire 2,000 shares of a target company with a registered capital of only 10,000 Hong Kong dollars, raising questions about the necessity of the acquisition [1] - The Shanghai Stock Exchange expressed confusion regarding the rationale behind this acquisition, highlighting the unusual nature of the transaction [1]